Al Razi Medical Company vs Almujtama Alraida Medical Co.
A head-to-head of Al Razi Medical Company (9572) and Almujtama Alraida Medical Co. (9592) across valuation, profitability, growth, and dividends. Green marks the more favourable value on that metric only — not a recommendation.
| Metric | 9572 | 9592 |
|---|---|---|
| Market Cap | 43.05M SAR | 213.75M SAR |
| P/E (TTM) | 58.85 | 25.18 |
| Forward P/E | — | — |
| P/S | 0.58 | — |
| P/B | 2.06 | 1.44 |
| EV/EBITDA | 16.74 | — |
| Dividend Yield | — | 111.00% |
| Profit Margin | 1.10% | 1.85% |
| Gross Margin | 25.94% | 32.93% |
| Operating Margin | 2.65% | 2.36% |
| Revenue Growth (YoY) | +34.00% | — |
| FCF Yield | — | — |
| Debt / Equity | 11.78 | — |
| Current Ratio | 1.47 | 1.07 |
Which is better: Al Razi Medical Company or Almujtama Alraida Medical Co.?
- ✓Larger by market cap: Almujtama Alraida Medical Co.
- ✓Cheaper valuation (lower P/E): Almujtama Alraida Medical Co.
- ✓More profitable (net margin): Almujtama Alraida Medical Co.
Across 6 available metrics, Almujtama Alraida Medical Co. leads 4–2.
There's no single "better" — it depends on your goal: income investors may prefer the higher yield, growth investors the faster grower, and value investors the cheaper one. See each stock's page for deeper detail. This is an automated read, not a recommendation.
Share:
Compare Al Razi Medical Company with others
This comparison is for informational and educational purposes only, based on available data — not a recommendation to buy or sell any stock.